AR026487A1 - Derivados de espiro[2h-1-benzopiran-2,4'-piperidina] para el uso en terapia, especificamente para el tratamiento de alteraciones del snc - Google Patents
Derivados de espiro[2h-1-benzopiran-2,4'-piperidina] para el uso en terapia, especificamente para el tratamiento de alteraciones del sncInfo
- Publication number
- AR026487A1 AR026487A1 ARP000106034A ARP000106034A AR026487A1 AR 026487 A1 AR026487 A1 AR 026487A1 AR P000106034 A ARP000106034 A AR P000106034A AR P000106034 A ARP000106034 A AR P000106034A AR 026487 A1 AR026487 A1 AR 026487A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- optionally substituted
- hydrogen
- derivatives
- piperidine
- Prior art date
Links
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 229910052736 halogen Inorganic materials 0.000 abstract 6
- 150000002367 halogens Chemical class 0.000 abstract 6
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 5
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- 125000003118 aryl group Chemical group 0.000 abstract 3
- 125000001424 substituent group Chemical group 0.000 abstract 3
- FUFZNHHSSMCXCZ-UHFFFAOYSA-N 5-piperidin-4-yl-3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole Chemical compound FC(F)(F)C1=CC=CC(C=2N=C(ON=2)C2CCNCC2)=C1 FUFZNHHSSMCXCZ-UHFFFAOYSA-N 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 150000002431 hydrogen Chemical class 0.000 abstract 2
- 125000003003 spiro group Chemical group 0.000 abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 abstract 1
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 206010012289 Dementia Diseases 0.000 abstract 1
- 102000010726 Glycine Plasma Membrane Transport Proteins Human genes 0.000 abstract 1
- 108010063380 Glycine Plasma Membrane Transport Proteins Proteins 0.000 abstract 1
- 208000008238 Muscle Spasticity Diseases 0.000 abstract 1
- 102000004868 N-Methyl-D-Aspartate Receptors Human genes 0.000 abstract 1
- 108090001041 N-Methyl-D-Aspartate Receptors Proteins 0.000 abstract 1
- 125000005133 alkynyloxy group Chemical group 0.000 abstract 1
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000004104 aryloxy group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000000 cycloalkoxy group Chemical group 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 206010015037 epilepsy Diseases 0.000 abstract 1
- 125000004446 heteroarylalkyl group Chemical group 0.000 abstract 1
- 125000005553 heteroaryloxy group Chemical group 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 208000018198 spasticity Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Derivados de espiro[2H-1-benzopiran-2,4-piperidina] que tienen la formula general (1) donde la línea de puntos representa un enlace opcional; Y representa1-4 sustituyentes seleccionados independientemente entre hidrogeno, halogeno, alquilo C1-6 (opci onalmente sustituido con uno o más halogenos), alquiloxi C1-6(opcionalmente sustituido con uno o más halogenos o con cicloalquilo C3-6), alqueniloxi C2-6, alquiniloxi C2-6, cicloalquiloxi C3-6, ariloxi C6-12,arilalquiloxi, heteroariloxi, heteroarilal quiloxi, SR3, NR3R4, OSO2R5 y NR3SO2R4; 2 sustituyentes Y pueden formar juntos O-(CH2)n-O u O-(CF2)n-O, donde n es 1o 2; o bien Y representa un grupo arilo C5-6 fusionado; X representa 1-3 sustituyentes seleccionados independientemente entre hidrogen o, halogeno, hidroxi,alquiloxi C1-4, SR3, NR3SO2R4 y alquilo C1-4, opcionalmente sustituido con halogeno; R1 es hidrogeno, alquilo C1-4 o arilo C6-12; R2, R3 y R4 sonindependientemente hidrogeno o alquilo C1-4; R5 es alquilo C1-4 (opcionalmente susti tuido con uno o más halogenos) o arilo C6-12 (opcionalmente sustituido conalquilo C1-4); o una sal farmacéuticamente aceptable del mismo. Composiciones farmacéuticas que comprenden dichos derivados. Uso de estos derivados deespiro[2H-1-benzopiran-2,4 -piperidina] para preparar un medicamento. Estos compuestos que alteran la actividad de los transportadores de glicina provocancambios en los tejidos pudiendo ser utiles en el tratamiento de trastornos asociados a la funcion disminuida o exagerada de los receptores de NMDA, comopsicosis, depresion, demencia y también otras como la enfermedad de Alzheimer, Parkinson, espasticidad y epilepsia. También pueden tener propiedadesanalgésicas.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99309137 | 1999-11-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR026487A1 true AR026487A1 (es) | 2003-02-12 |
Family
ID=8241739
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP000106034A AR026487A1 (es) | 1999-11-17 | 2000-11-16 | Derivados de espiro[2h-1-benzopiran-2,4'-piperidina] para el uso en terapia, especificamente para el tratamiento de alteraciones del snc |
Country Status (29)
| Country | Link |
|---|---|
| US (2) | US6645973B1 (es) |
| EP (1) | EP1232160B1 (es) |
| JP (1) | JP4825386B2 (es) |
| KR (1) | KR100776226B1 (es) |
| CN (1) | CN1199974C (es) |
| AR (1) | AR026487A1 (es) |
| AT (1) | ATE398622T1 (es) |
| AU (1) | AU779518B2 (es) |
| BR (1) | BR0015586A (es) |
| CA (1) | CA2389491C (es) |
| CO (1) | CO5261618A1 (es) |
| CY (1) | CY1108339T1 (es) |
| CZ (1) | CZ293920B6 (es) |
| DE (1) | DE60039247D1 (es) |
| DK (1) | DK1232160T3 (es) |
| ES (1) | ES2307536T3 (es) |
| HK (1) | HK1047282B (es) |
| HU (1) | HUP0204162A3 (es) |
| IL (2) | IL149286A0 (es) |
| NO (1) | NO327743B1 (es) |
| NZ (1) | NZ518671A (es) |
| PE (1) | PE20010750A1 (es) |
| PL (1) | PL206071B1 (es) |
| PT (1) | PT1232160E (es) |
| RU (1) | RU2250211C2 (es) |
| SK (1) | SK287040B6 (es) |
| TW (1) | TWI243173B (es) |
| WO (1) | WO2001036423A1 (es) |
| ZA (1) | ZA200203320B (es) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI243173B (en) * | 1999-11-17 | 2005-11-11 | Akzo Nobel Nv | Spiro[2H-1-benzopyran-2,4'-piperidine] derivatives |
| FR2842804B1 (fr) * | 2002-07-29 | 2004-09-03 | Sanofi Synthelabo | Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique |
| KR101255074B1 (ko) * | 2003-10-01 | 2013-04-16 | 아돌로 코포레이션 | 스피로시클릭 헤테로시클릭 유도체 및 이의 사용 방법 |
| BRPI0418375A (pt) * | 2004-01-08 | 2007-05-22 | Hoffmann La Roche | derivados de diaza-espiropiperidina |
| PL1716147T3 (pl) * | 2004-01-08 | 2008-03-31 | Hoffmann La Roche | Pochodne diazaspiropiperydyny jako inhibitory transportera 1 glicyny i transportera 2 glicyny |
| US20050209317A1 (en) * | 2004-03-22 | 2005-09-22 | Apkarian A V | Method and compositions for treatment of chronic neuropathic pain |
| PT1848694E (pt) * | 2005-02-07 | 2010-02-02 | Hoffmann La Roche | Fenil-metanonas heterocíclicas substituídas, como inibidores do transportador de glicina 1 |
| CN101184749B (zh) * | 2005-03-31 | 2012-12-05 | 阿得罗公司 | 螺环杂环衍生物及其使用方法 |
| US7598261B2 (en) * | 2005-03-31 | 2009-10-06 | Adolor Corporation | Spirocyclic heterocyclic derivatives and methods of their use |
| EP1910375B1 (en) * | 2005-07-19 | 2011-05-11 | Merck Sharp & Dohme Corp. | Spirochromanone derivatives as acetyl coenzyme a carboxylase (acc) inhibitors |
| US7576207B2 (en) * | 2006-04-06 | 2009-08-18 | Adolor Corporation | Spirocyclic heterocyclic derivatives and methods of their use |
| EP2024370A1 (en) * | 2006-05-05 | 2009-02-18 | Boehringer Ingelheim International GmbH | Spiro- (tho) benzopyran-2, 4' -piperidine-and cyclohexane derivatives as inhibitors of specific cell cycle enzymes |
| ES2406085T3 (es) * | 2006-06-22 | 2013-06-05 | F. Hoffmann-La Roche Ag | Derivados de fenil-metanona sustituida y su empleo como inhibidores de receptores de GlyT1 y GlyT2 |
| JP2010503669A (ja) * | 2006-09-12 | 2010-02-04 | アドラー コーポレーション | 認知機能の強化のためのｎ含有スピロ化合物の使用 |
| TWI366565B (en) | 2007-06-06 | 2012-06-21 | Otsuka Pharma Co Ltd | Quinolone compound and pharmaceutical composition |
| KR100888468B1 (ko) * | 2007-08-31 | 2009-03-11 | 한국화학연구원 | 항암활성을 갖는1'-알킬피페리딘-4'-스피로-2-6-(아미도)-2ｈ-벤조피란유도체 |
| WO2009039431A2 (en) * | 2007-09-21 | 2009-03-26 | Neurogen Corporation | Substituted aryl-fused spirocyclic amines |
| RU2358977C1 (ru) * | 2008-04-02 | 2009-06-20 | Московская государственная академия тонкой химической технологии им. М.В. Ломоносова Государственное образовательное учреждение высшего профессионального образования | 5-формил-замещенные индолиновые спиробензопираны и способ их получения |
| EP2380595A1 (en) | 2010-04-19 | 2011-10-26 | Nlife Therapeutics S.L. | Compositions and methods for selective delivery of oligonucleotide molecules to specific neuron types |
| RU2435774C1 (ru) * | 2010-07-05 | 2011-12-10 | Государственное образовательное учреждение высшего профессионального образования "Пермский государственный университет" | Этил-2-амино-7,7-диметил-2',5-диоксо-5'-фенил-1',2',5,6,7,8-гексагидроспиро[хромен-4,3'-пиррол]-4'-карбоксилаты и способ их получения |
| TWI543984B (zh) * | 2010-07-09 | 2016-08-01 | 艾伯維公司 | 作為s1p調節劑的螺-哌啶衍生物 |
| US20170143681A1 (en) | 2015-11-02 | 2017-05-25 | Apkarian Technologies Llc | Methods and compositions for treating pain |
| CN116621187B (zh) * | 2023-07-24 | 2023-09-22 | 江苏泓顺硅基半导体科技有限公司 | 一种用于高温氯化提纯石英砂的设备 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ243065A (en) * | 1991-06-13 | 1995-07-26 | Lundbeck & Co As H | Piperidine derivatives and pharmaceutical compositions |
| FR2689509B1 (fr) * | 1992-04-01 | 1994-06-03 | Adir | Nouveaux derives spiraniques du 3-amino chromane, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent. |
| DK78692D0 (da) | 1992-06-12 | 1992-06-12 | Lundbeck & Co As H | Dimere piperidin- og piperazinderivater |
| IL107881A0 (en) | 1992-12-05 | 1994-04-12 | Fisons Corp | Furanone derivatives and pharmaceutical compositions containing them |
| CA2155108A1 (en) * | 1993-02-12 | 1994-08-18 | John J. Baldwin | Nitrogen-containing spirocycles |
| US5484923A (en) | 1993-06-10 | 1996-01-16 | Merck & Co., Inc. | Process of making spirocycles and analogs thereof |
| US5439914A (en) | 1994-02-18 | 1995-08-08 | Merck & Co., Inc. | Spirocycles |
| GB9421003D0 (en) * | 1994-10-18 | 1994-12-07 | Smithkline Beecham Plc | Novel compounds |
| US5654316A (en) * | 1995-06-06 | 1997-08-05 | Schering Corporation | Piperidine derivatives as neurokinin antagonists |
| WO1997020553A1 (en) | 1995-12-07 | 1997-06-12 | Javitt Daniel C | Treatment of negative and cognitive symptoms of schizophrenia with glycine uptake antagonists |
| HUP9600928A3 (en) | 1996-04-10 | 1999-03-29 | Richter Gedeon Vegyeszet | Use of spiro[2h-1-benzopyran-2,4'-piperidin]-4(3h)-one derivatives for the preparation of pharmaceutical compositions treating dementia, novel derivatives and process for their preparation |
| SI1014966T1 (sl) | 1996-05-31 | 2006-10-31 | Allelix Neuroscience Inc | Zdravilo za zdravljenje nevroloskih in nevripsihiatricnih bolezni |
| CA2255727A1 (en) | 1996-05-31 | 1997-12-04 | Trophix Pharmaceuticals, Inc. | Pharmaceutical for treating of neurological and neuropsychiatric disorders |
| US5919653A (en) | 1996-08-20 | 1999-07-06 | Allelix Neuroscience Inc. | Nucleic acids encoding a human glycine transporter |
| AU2030999A (en) | 1998-01-09 | 1999-07-26 | Allelix Neuroscience, Inc. | Glycine transport inhibitors |
| TW555757B (en) | 1998-07-31 | 2003-10-01 | Akzo Nobel Nv | Aminomethylcarboxylic acid derivatives |
| TWI243173B (en) * | 1999-11-17 | 2005-11-11 | Akzo Nobel Nv | Spiro[2H-1-benzopyran-2,4'-piperidine] derivatives |
| AU2001252269A1 (en) * | 2000-04-27 | 2001-11-12 | Basilea Pharmaceutica Ag | Chromenylmethyl pyrimidinediamines as antibacterial agents |
-
2000
- 2000-11-08 TW TW089123584A patent/TWI243173B/zh not_active IP Right Cessation
- 2000-11-13 AT AT00977546T patent/ATE398622T1/de not_active IP Right Cessation
- 2000-11-13 CA CA2389491A patent/CA2389491C/en not_active Expired - Fee Related
- 2000-11-13 WO PCT/EP2000/011351 patent/WO2001036423A1/en not_active Ceased
- 2000-11-13 BR BR0015586-1A patent/BR0015586A/pt not_active Application Discontinuation
- 2000-11-13 NZ NZ518671A patent/NZ518671A/en unknown
- 2000-11-13 CN CNB008157901A patent/CN1199974C/zh not_active Expired - Fee Related
- 2000-11-13 DE DE60039247T patent/DE60039247D1/de not_active Expired - Lifetime
- 2000-11-13 US US10/130,557 patent/US6645973B1/en not_active Expired - Lifetime
- 2000-11-13 KR KR1020027006305A patent/KR100776226B1/ko not_active Expired - Fee Related
- 2000-11-13 PL PL355975A patent/PL206071B1/pl not_active IP Right Cessation
- 2000-11-13 PT PT00977546T patent/PT1232160E/pt unknown
- 2000-11-13 SK SK843-2002A patent/SK287040B6/sk not_active IP Right Cessation
- 2000-11-13 RU RU2002115862/04A patent/RU2250211C2/ru not_active IP Right Cessation
- 2000-11-13 AU AU15219/01A patent/AU779518B2/en not_active Ceased
- 2000-11-13 IL IL14928600A patent/IL149286A0/xx active IP Right Grant
- 2000-11-13 HU HU0204162A patent/HUP0204162A3/hu unknown
- 2000-11-13 ES ES00977546T patent/ES2307536T3/es not_active Expired - Lifetime
- 2000-11-13 EP EP00977546A patent/EP1232160B1/en not_active Expired - Lifetime
- 2000-11-13 CZ CZ20021724A patent/CZ293920B6/cs not_active IP Right Cessation
- 2000-11-13 JP JP2001538912A patent/JP4825386B2/ja not_active Expired - Fee Related
- 2000-11-13 DK DK00977546T patent/DK1232160T3/da active
- 2000-11-13 HK HK02108962.5A patent/HK1047282B/en not_active IP Right Cessation
- 2000-11-16 PE PE2000001227A patent/PE20010750A1/es not_active Application Discontinuation
- 2000-11-16 AR ARP000106034A patent/AR026487A1/es unknown
- 2000-11-17 CO CO00087799A patent/CO5261618A1/es not_active Application Discontinuation
-
2002
- 2002-04-23 IL IL149286A patent/IL149286A/en not_active IP Right Cessation
- 2002-04-25 ZA ZA200203320A patent/ZA200203320B/xx unknown
- 2002-05-15 NO NO20022320A patent/NO327743B1/no not_active IP Right Cessation
-
2003
- 2003-08-08 US US10/637,681 patent/US7507824B2/en not_active Expired - Lifetime
-
2008
- 2008-09-15 CY CY20081100992T patent/CY1108339T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR026487A1 (es) | Derivados de espiro[2h-1-benzopiran-2,4'-piperidina] para el uso en terapia, especificamente para el tratamiento de alteraciones del snc | |
| AR046600A1 (es) | Diazaespiroalcanos y su uso como tratamiento para enfermedades mediadas por ccr8 | |
| ES2309594T3 (es) | Composiciones que contienen bloqueadores de los canales de calcio de tipo l e inhibidores de la colinesterasa. | |
| ATE398618T1 (de) | Pharmazeutische zusammensetzungen zur behandlung von zns und anderen krankheiten | |
| BG98793A (bg) | Нови производни на аминокиселините,методи за тяхното получаване и фармацевтични състави,съдържащи тези съединения | |
| AR049670A1 (es) | Un derivado de acido aminometil carboxilico, su uso en el tratamiento de alteraciones del snc y una composicion farmaceutica que lo contiene | |
| CO5021129A1 (es) | Nuevos compuestos farmaceuticos derivados de pleuromutilina y metodos para su preparacion | |
| NO306457B1 (no) | 2,4-disulfonylfenylbutylnitron, salter derav, farmasöytisk sammensetning, samt anvendelse av denne forbindelse til fremstilling av et medikament | |
| PA8442201A1 (es) | Derivados de 6-fenilpiridil-2-amina | |
| PA8456901A1 (es) | 2-aminopiridinas que contienen sustituyentes de anillos condensados | |
| ES2164889T3 (es) | Semicarbazonas con actividad sobre el snc y preparados farmaceuticos a base de las mismas. | |
| AR034283A1 (es) | Compuestos heterociclilindazol y azaindazol como ligandos de 5-hidroxitriptamina-6, un procedimiento para su preparacion, composicion farmaceutica y el uso de los mismos para la fabricacion de un medicamento | |
| AR043998A1 (es) | Acidos fenoxiaceticos | |
| CO5031253A1 (es) | Antagonistas receptores y5 de neuropeptidos composiciones farmaceuticas que las contienen | |
| AR022303A1 (es) | Derivados de piperidina, tetrahidropiridina y piperazina, su preparacion y utilizacion | |
| DE60043349D1 (de) | Chinazolin-derivate und ihre verwendung als arzneimittel | |
| GEP20012555B (en) | Pyrazine Compounds, Method for Its Production, Their Use As a Medicinal Means, Pharmaceutical Composition and Method for Treatment | |
| AR004708A1 (es) | Un derivado de 5-fenil-3-(piperidin-4-il)-1,3,4-oxadiazol-2(3h)-ona, un medicamento, una composicion farmaceutica que lo comprende y un procedimiento de preparacion de dicho derivado. | |
| NO975709D0 (no) | Nye 19-nor-pregnan-steroider for indusering av hypototalamiske effekter | |
| RU94030812A (ru) | Производные фосфоноянтарной кислоты, способ их получения и содержащие эти соединения фармацевтические композиции | |
| AR029373A1 (es) | Metodo para el tratamiento de migranas, utilizando compuestos antagonistas selectivos de los receptores iglur5, uso de dichos compuestos antagonistas selectivos en la manufactura de medicamentos para el tratamiento de migranas y dichos compuestos antagonistas | |
| MX2008015860A (es) | Combinaciones que comprenden moduladores de 5ht6 e inhibidores de la colinesterasa. | |
| CO5160242A1 (es) | UTILIZACION DE DERIVADOS DE PIRIDAZINO [4,5-b] INDOL-1- ACETAMIDA, PARA LA PREPARACION DE MEDICAMENTOS DESTINADOS A LAS ENFERMEDADES DEL SISTEMA NERVIOSO CENTRAL | |
| AR015446A1 (es) | Antagonistas de receptores de vitronectina, composicion farmaceutica que los contiene, procedimiento para su preparacion, su uso para la elaboracion de unmedicamento y compuestos intermediarios | |
| AR005233A1 (es) | Derivados de 1,2,3,4-tetrahidroquinolina, procesos para su preparacion, una composicion farmaceutica y el uso en la elaboracion de un medicamento |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |